GMABLARGE

Genmab A/S

HealthcareBiotechnology
$29.18
$0.01(+4.18%)
52W$20.79
$35.43
Updated Jul 8, 02:00 AM
RSI64
RS Rating43/99
Beta0.80
Volatility35%
F-Score4/9
Mkt Cap$17.9B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Genmab A/S is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 43), showing significant lag compared to the market leaders. Earnings contraction of 73% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
43
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.80
vs S&P 500
DEFENSIVE
52W Position
57%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$26.26
50 SMA > 100 SMA$27.02
100 SMA > 150 SMA$28.83
150 SMA > 200 SMA$29.23

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$26.06+11.97%ABOVE
50 SMA$26.26+11.12%ABOVE
100 SMA$27.02+8.00%ABOVE
150 SMA$28.83+1.20%ABOVE
200 SMA$29.23-0.15%BELOW

Price Performance

1D+4.2%
1W+6.2%
1M+17.7%
3M+5.5%
6M-13.9%
YTD-8.3%
1Y+42.2%
3Y-8.2%
52-Week Trading Range57% from low
$29.18
52W Low$20.79
52W High$35.43

Technical Indicators

RSI (14)BULLISH
64.4
305070
Setup ScoreHOT
7/10
Base depth: 19.9%

Risk Profile

Beta
0.80
52W Vol
35%
ATR
$0.78
Max DD (1Y)
-33%

Volume Analysis

Today
1.53M
50D Avg
1.81M
Vol Ratio
0.84x
Liquidity
MODERATE

Earnings Momentum

Q2'25+58%
$3.42
Q3'25-67%
$0.65
Q4'25-99%
$0.05
Q1'26-73%
$0.08
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+12.63%
5 Years:-18.11%
3 Years:-36.45%
TTM:-34.41%

Compounded Profit Growth

10 Years:+2.03%
5 Years:-26.58%
3 Years:-42.87%
TTM:-59.70%

Stock Price CAGR

10 Years:+5.10%
5 Years:-7.34%
3 Years:-8.17%
1 Year:+42.20%

Return on Equity

10Y Avg:19.6%
5Y Avg:15.7%
3Y Avg:14.1%
Last Year:20.6%

Key Metrics

Market Cap$17.9B
Gross Margin91.7%
Net Margin25.9%
Piotroski F-Score4/9

Frequently Asked Questions

Is GMAB in an uptrend right now?

GMAB has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is GMAB overbought or oversold?

GMAB's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.

Is GMAB outperforming the market?

GMAB has a Relative Strength (RS) Rating of 43 out of 99. GMAB is currently lagging the broader market.

Where is GMAB in its 52-week range?

GMAB is trading at $29.18, which is 82% of its 52-week high ($35.43) and 57% above its 52-week low ($20.79).

How volatile is GMAB?

GMAB has a Beta of 0.80 and 52-week volatility of 35%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.